Meet the Expert: Tina Watts, BSN, RN, MD-WCCM

Preclinical results for an anticancer drug developed under the auspices of the NCI RAS Initiative were recently reported in Cancer Discovery. The drug, BBO-11818, hindered tumor growth or shrank tumors in laboratory and mouse models of non-small cell lung cancer, pancreatic ductal adenocarcinoma, and colorectal cancer.

The HIV DRP’s 28th annual Think Tank was a virologist’s field day. Nineteen lectures spanned the symposium’s more than eight-hour itinerary. Many were given by or featured the work of postbaccalaureate and postdoctoral fellows. Here are a few excerpts.

On September 9, the Technology Showcase returns to the Advanced Technology Research Facility for its ninth year. In addition to showcasing cutting-edge biomedical technologies developed at the Frederick National Laboratory for Cancer Research and National Cancer Institute, the event offers educational and networking opportunities for companies, investors, entrepreneurs, technology scouts, and other biotech stakeholders.

Scientific leaders from government, industry, academia, and publishing identified and proposed solutions to one of the most complex challenges facing scientists today—reproducibility in research—at the recent Hood College – Frederick National Laboratory Life Sciences Symposium.

NCI Frederick and FNLCR have an excellent OSHA safety record built on prevention, education, and rapid response. Behind that success is a dedicated network of professionals. One of those individuals is Tina Watts, BSN, RN, MD-WCCM, occupational health nurse and workers’ compensation case manager, whose steady guidance and compassionate approach have become well known across campus.